Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Kessel: Lens fluorescence and metabolic control in type 1 diabetic patients: a 14 year follow.... (0.22 sec) 

Lens fluorescence and metabolic control in type 1 diabetic patients: a 14 year …

- bmj.com
L Kessel, B Sander, P Dalgaard, M Larsen - British Medical Journal, 2004 - bjo.bmj.com
Conclusion: The results confirm that the rate of fluorophore accumulation in the lens of adult
diabetic patients is increased in proportion to glycaemic control. This parameter alone is, however,
not sufficient to explain the ...
Cited by 6 - Related articles - BL Direct - All 9 versions

Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma …

- scoutscreening.com [PDF]  - Free from Publisher
JD Maynard, M Rohrscheib, JF Way, CM Nguyen, … - Diabetes care, 2007 - Am Diabetes Assoc
RESULTS—Subjects with 2-h OGTT values ≥140 mg/dl defined the positive screening class. A total
of 84 subjects (23.9% prevalence) screened positive. The performances of the noninvasive device,
FPG, and A1C were evaluated for ...
Cited by 12 - Related articles - BL Direct - All 16 versions

Accumulation of Advanced Glycation End Products and Chronic Complications in …


R Meerwaldt, CJ Zeebregts, G Navis, JL … - American Journal of …, 2009 - Elsevier
Cardiovascular and connective tissue disorders are very common in patients with end-stage renal
disease (ESRD), and the accumulation of advanced glycation end products (AGEs) is significantly
increased in these patients. ...
Cited by 1 - Related articles - All 3 versions

[PDF] Cardiovascular Diabetology


R Meerwaldt, T Links, C Zeebregts, R Tio, JL … - Cardiovascular …, 2008 - zevep.com
Address: 1Department of Surgery, Isala Clinics, Zwolle, The Netherlands, 2Department of
Endocrinology, University Medical Center Groningen, Groningen, The Netherlands, 3Department of
Vascular Surgery, University ...
Related articles - View as HTML

Lens autofluorescence is not increased at high altitude


L Kessel, PK Kofoed, G Zubieta-Calleja, M Larsen, N … - Acta Opthalmol - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets. In
this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the ...
Cited by 1 - Related articles - All 2 versions

—to: Davis BJ, Forbes JM, Thomas MC et al.(2004) Superior renoprotective effects …


SK Biswas, JM Lopes De Faria, JB Lopes De Faria - Diabetologia, 2004 - Springer
To the Editor: We read with interest the recent paper by Davis et al. [1] reporting the
renoprotective effects of an ACE inhibi- tor, an AGE inhibitor and a combined ACE and AGE inhibitor
on streptozotocin-induced diabetic ...
Cited by 1 - Related articles

The clinical relevance of assessing advanced glycation endproducts accumulation …


R Meerwaldt, T Links, C Zeebregts, R Tio, JL … - Cardiovascular …, 2008 - cardiab.com
Cardiovascular disease is the major cause of morbidity and mortality associated with diabetes. There
is increasing evidence that advanced glycation endproducts (AGEs) play a pivotal role in
atherosclerosis, in particular in ...
Cited by 1 - Related articles - Cached - All 8 versions

Skin Autofluorescence

- diabetesjournals.org
EG Gerrits, HL Lutgers, N Kleefstra, R Graaff, KH … - Diabetes Care, 2008 - Am Diabetes Assoc
OBJECTIVE—Skin autofluorescence is a noninvasive measure of the level of tissue accumulation of
advanced glycation end products, representing cumulative glycemic and oxidative stress. Recent
studies have already shown a ...
Cited by 10 - Related articles - BL Direct - All 7 versions

Mortality within the first 10 years of the disease in type 2 diabetic patients


S Bo, G Ciccone, R Gancia, R Rosato, G Grassi, F … - Nutrition, Metabolism and …, 2006 - Elsevier
A mortality follow-up was carried out in 1200 patients with ≤5 years diabetes duration and 2692
patients with >5 (median 2 and 15) years diabetes duration in 1995. Four-year survival was 92.0% and
83.7%, respectively; most deaths ...
Cited by 9 - Related articles - All 7 versions

[PDF] Serum levels of advanced glycation end products are associated with in-stent …


EY Choi, HM Kwon, CW Ahn, GT Lee, B Joung, BK … - Yonsei Med J, 2005 - ymj.or.kr
Advanced Glycation End Products and Restenosis 79 the role of AGEs with regard to restenosis in
human coronary artery disease (CAD) remains unknown. Therefore, we attempted to determine whether
serum AGE levels are associated ...
Cited by 10 - Related articles - All 8 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google